These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 7731709

  • 21. Multiple regions within EBNA1 can link DNAs.
    Mackey D, Middleton T, Sugden B.
    J Virol; 1995 Oct; 69(10):6199-208. PubMed ID: 7666521
    [Abstract] [Full Text] [Related]

  • 22. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma.
    Wang WY, Chien YC, Jan JS, Chueh CM, Lin JC.
    Clin Cancer Res; 2002 Aug; 8(8):2586-90. PubMed ID: 12171888
    [Abstract] [Full Text] [Related]

  • 23. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.
    Tellam JT, Lekieffre L, Zhong J, Lynn DJ, Khanna R.
    PLoS Pathog; 2012 Dec; 8(12):e1003112. PubMed ID: 23300450
    [Abstract] [Full Text] [Related]

  • 24. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells.
    Huo S, Luo Y, Deng R, Liu X, Wang J, Wang L, Zhang B, Wang F, Lu J, Li X.
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33122398
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.
    O'Neil JD, Owen TJ, Wood VHJ, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS.
    J Gen Virol; 2008 Nov; 89(Pt 11):2833-2842. PubMed ID: 18931081
    [Abstract] [Full Text] [Related]

  • 26. The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal.
    Chao M, Wang HN, Lu YJ, Chang YS, Yu JS.
    Oncol Rep; 2015 Feb; 33(2):958-66. PubMed ID: 25434292
    [Abstract] [Full Text] [Related]

  • 27. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
    Cheng TC, Hsieh SS, Hsu WL, Chen YF, Ho HH, Sheu LF.
    Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPS but not EBNA2 in vivo.
    Laytragoon-Lewin N, Chen F, Avila-Carino J, Zou JZ, Mellstedt H, Ernberg I, Klein G.
    Int J Cancer; 1996 Mar 01; 65(5):714-5. PubMed ID: 8598328
    [No Abstract] [Full Text] [Related]

  • 31. Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a "Bookmarking" Oncoprotein that Alters the Host Cell Epigenotype?
    Niller HH, Minarovits J.
    Pathogens; 2012 Sep 17; 1(1):37-51. PubMed ID: 25436603
    [Abstract] [Full Text] [Related]

  • 32. The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration.
    Bridgewater HE, Date KL, O'Neil JD, Hu C, Arrand JR, Dawson CW, Young LS.
    Pathogens; 2020 Jul 21; 9(7):. PubMed ID: 32708289
    [Abstract] [Full Text] [Related]

  • 33. EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.
    Wilson JB, Manet E, Gruffat H, Busson P, Blondel M, Fahraeus R.
    Cancers (Basel); 2018 Apr 06; 10(4):. PubMed ID: 29642420
    [Abstract] [Full Text] [Related]

  • 34. A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers.
    Hosseini Tabatabaie F, Hosseini SY, Hashemi SMA, Safaie A, Sarvari J.
    Iran J Pathol; 2023 Apr 06; 18(1):24-32. PubMed ID: 37383155
    [Abstract] [Full Text] [Related]

  • 35. Genotype characterization of Epstein-Barr virus among adults living with human immunodeficiency virus in Ethiopia.
    Zealiyas K, Teshome S, Haile AF, Weigel C, Alemu A, Amogne W, Yimer G, Abebe T, Berhe N, Ahmed EH, Baiocchi RA.
    Front Microbiol; 2023 Apr 06; 14():1270824. PubMed ID: 38029140
    [Abstract] [Full Text] [Related]

  • 36. Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies.
    Tabibzadeh A, Karbalaie Niya MH, Esghaei M, Bokharaei-Salim F, Ataei-Pirkooh A, Kiani SJ, Monavari SHR.
    Asian Pac J Cancer Prev; 2020 Mar 01; 21(3):693-698. PubMed ID: 32212795
    [Abstract] [Full Text] [Related]

  • 37. Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam.
    Thuan LD, Kha ND, Minh NT, Thuy L.
    Balkan J Med Genet; 2019 Jun 01; 22(1):61-68. PubMed ID: 31523622
    [Abstract] [Full Text] [Related]

  • 38. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N, Ku W, Song Y, Zhu J, Lu Z.
    Oncologist; 2019 Sep 01; 24(9):e905-e913. PubMed ID: 30940744
    [Abstract] [Full Text] [Related]

  • 39. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM.
    Oncotarget; 2017 Jan 31; 8(5):7248-7264. PubMed ID: 28077791
    [Abstract] [Full Text] [Related]

  • 40. Identification and Characterization of Epstein-Barr Virus Genomes in Lung Carcinoma Biopsy Samples by Next-Generation Sequencing Technology.
    Wang S, Xiong H, Yan S, Wu N, Lu Z.
    Sci Rep; 2016 May 18; 6():26156. PubMed ID: 27189712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.